WellSky
As novel cell and gene therapies continue to expand, you need a solution that can manage the complete product development process from discovery and development through pre-clinical and clinical research, through post-market safety monitoring. WellSky Biotherapies allows you to build workflows and manufacturing procedures to effectively manage autologous and allogeneic protocols. It expands your ability to centralize and share data through a single system while decreasing batch review, approval, and release times, accelerating understanding of therapeutic outcomes.